Skip to main content
. 2002 Jan;160(1):175–183. doi: 10.1016/S0002-9440(10)64361-1

Table 2.

Molecular Expression Profiles of Cell-Cycle Regulators in Hürthle Cell Neoplasms (n = 69) and Normal Thyroid Tissues (n = 18)

Marker Normal (n = 18) Adenoma (n = 27) UMB (n = 7) Mi (n = 14) Wi (n = 21)
p53
Negative 18 (100%) 25 (92.6%) 7 (100%) 12 (85.7%) 15 (71.4%)
Positive 0 (0%) 2 (7.4%) 0 (0%) 1 (7.1%) 4 (19%)
mdm-2
Negative 16 (88.9%) 5 (18.5%) 0 (0%) 2 (14.3%) 5 (23.8%)
Positive 1 (5.6%) 19 (70.4%) 5 (71.4%) 8 (57.1%) 12 (57.1%)
p21
Negative 17 (94.4%) 7 (25.9%) 3 (42.9%) 4 (28.6%) 8 (38.1%)
Positive 0 (0%) 17 (63%) 4 (57.1%) 6 (42.9%) 9 (42.9%)
Bcl-2
Negative 0 (0%) 3 (11.1%) 2 (28.6%) 4 (28.6%) 5 (23.8%)
Positive 18 (100%) 21 (77.8%) 5 (71.4%) 6 (42.9%) 12 (57.1%)
Cyclin D1
Negative 18 (100%) 25 (92.6%) 7 (100%) 11 (78.6%) 17 (81.0%)
Positive 0 (0%) 1 (3.7%) 0 (0%) 0 (0%) 1 (4.8%)

Mi, minimally invasive carcinoma; Wi, widely invasive carcinoma; UMB, Hürthle cell tumor of unknown malignant behavior.

Number of patients in subgroups less than total number in respective group reflects tissue loss during tissue microarray processing.